Please use this identifier to cite or link to this item:
http://sgc.anlis.gob.ar/handle/123456789/1739
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sosa-Estani, Sergio | es |
dc.contributor.author | Segura, Elsa L. | es |
dc.date.accessioned | 2020-11-25T13:56:26Z | - |
dc.date.available | 2020-11-25T13:56:26Z | - |
dc.date.issued | 1999 | - |
dc.identifier.issn | 1678-8060 | - |
dc.identifier.uri | http://sgc.anlis.gob.ar/handle/123456789/1739 | - |
dc.description | Fil: Sosa Estani, Sergio. ANLIS Dr.C.G.Malbrán. Centro Nacional de Diagnóstico e Investigación de Endemo-Epidemias; Argentina. | es |
dc.description | Fil: Segura, Elsa Leonor. ANLIS Dr.C.G.Malbrán. Centro Nacional de Diagnóstico e Investigación de Endemo-Epidemias; Argentina. | es |
dc.description.abstract | The goals of specific treatment against Trypanosoma cruzi infection, at an individual level, are to eliminate the parasite, to diminish the probability of developing illness (Chagas disease), and to hinder the chain of T. cruzi transmission as actions for the control of vectorial and non vectorial transmission (Sosa Estani 1993). Around 1930, investigations began in Argentina to obtain an effective drug against T. cruzi. Of all the substances evaluated, only nifurtimox (1972) and benznidazol (1974) have been accepted by the Ministry of Health as anti-T. cruzi drugs. Both drugs began to be assessed on the acute phase, and later, on the chronic phase of the disease | es |
dc.format | - | |
dc.language.iso | en | es |
dc.relation.ispartof | Memorias do Instituto Oswaldo Cruz | es |
dc.rights | Open Access | - |
dc.rights | Creative Commons Attribution 3.0 International License | - |
dc.rights.uri | https://creativecommons.org/licenses/by/3.0/deed.es | - |
dc.source | Memorias do Instituto Oswaldo Cruz 1994; 94(1):363-365 | - |
dc.subject | Trypanosoma cruzi | es |
dc.subject | Terapéutica | es |
dc.subject | Argentina | es |
dc.title | Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina | es |
dc.type | Artículo | es |
dc.identifier.doi | 10.1590/s0074-02761999000700070 | - |
anlis.essnrd | 1 | - |
item.cerifentitytype | Publications | - |
item.fulltext | With Fulltext | - |
item.grantfulltext | open | - |
item.languageiso639-1 | en | - |
item.openairetype | Artículo | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | Administración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán” (ANLIS) | - |
crisitem.author.dept | Administración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán” (ANLIS) | - |
crisitem.author.dept | Instituto Nacional de Parasitología (INP) | - |
crisitem.author.parentorg | Administración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos G. Malbrán” (ANLIS) | - |
Appears in Collections: | Publicaciones CeNDIE |
Files in This Item:
Page view(s)
15
checked on May 14, 2024
Download(s)
2
checked on May 14, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License